Which medication is abbreviated GDMT (guideline-directed medical therapy)?

GDMT is Not a Single Medication—It's a Multi-Drug Treatment Strategy

GDMT stands for Guideline-Directed Medical Therapy, which is not one medication but rather a combination of four medication classes used together to treat heart failure with reduced ejection fraction (HFrEF). 1

The Four Pillars of GDMT

According to the 2022 AHA/ACC/HFSA Heart Failure Guidelines, GDMT for HFrEF consists of "quadruple therapy" that includes 1:

1. Renin-Angiotensin System Inhibitors

   • ACE inhibitors (ACEi), OR
   • Angiotensin receptor blockers (ARB), OR
   • Angiotensin receptor-neprilysin inhibitors (ARNi)

2. Beta-blockers (evidence-based formulations)

3. Mineralocorticoid receptor antagonists (MRA)

4. Sodium-glucose cotransporter-2 inhibitors (SGLT2i)

Clinical Context

The term GDMT represents a paradigm shift in heart failure management—moving from single-drug approaches to comprehensive multi-drug therapy. All four medication classes should be initiated and titrated to maximally tolerated doses for optimal mortality and morbidity benefit 1, 2.

Real-World Implementation Gap

Despite strong guideline recommendations, actual implementation remains poor. Recent data shows that before hospitalization, only 1% of HFrEF patients receive quadruple therapy, and even after hospitalization, only 2% achieve this goal 3. Among those who do start therapy, discontinuation rates are alarmingly high: ARNi (62%), MRA (57%), SGLT2i (55%), and beta-blockers (51%) within 12 months 3.

Beyond HFrEF

GDMT terminology also applies to heart failure with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF), though with different medication classes and weaker recommendations 1.